GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: LCB18-055
Compound class:
Synthetic organic
|
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Summary of Clinical Use ![]() |
| GT-055 was developed to be used in combination with the siderophore-cephalosporin antibacterial GT-1 to treat multidrug-resistant (MDR) Gram-negative bacterial infections. We note that GT-055 is no longer included on the developer's (LigaChem Biosciences, formerly LegoChem Biosciences) pipeline web page, suggesting that development has ceased. |